Identification of Glucose-Dependent Insulin Secretion Targets in Pancreatic β Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing

Abstract

Identification and validation of novel drug targets continues to be a major bottleneck in drug development, particularly for polygenic complex diseases such as type 2 diabetes. Here, the authors describe an approach that allows researchers to rapidly identify and validate potential drug targets by combining chemical tools and RNA interference technology. As a proof-of-concept study, the known mechanism Sigma LOPAC library was used to screen for glucose-dependent insulin secretion (GDIS) in INS-1 832/13 cells. In addition to several mechanisms that are known to regulate GDIS (such as cyclic adenosine monophosphate—specific phosphodiesterases, adrenoceptors, and Ca²⁺ channels), the authors find that several of the dopamine receptor (DRD) antagonists significantly enhance GDIS, whereas DRD agonists profoundly inhibit GDIS. Subsequent siRNA studies in the same cell line indicate that knockdown of DRD2 enhanced GDIS. Furthermore, selective DRD2 antagonists and agonists also enhance or suppress, respectively, GDIS in isolated rat islets. The data support that the approach described here offers a rapid and effective way for target identification and validation. (Journal of Biomolecular Screening 2008;128-134)

Keywords

type 2 diabetes insulin secretion compound library screen siRNA

References

Kola I. , Landis J: Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3:711-715.

Schadt EE , Monks SA , Friend SH : A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets. Biochem Soc Trans 2003;31:437-443.

Schadt EE , Monks SA , Drake TA , Lusis AJ , Che N. , Colinayo V. , et al: Genetics of gene expression surveyed in maize, mouse and man . Nature 2003;422:297-302.

Schadt EE , Sachs A. , Friend S. : Embracing complexity, inching closer to reality. Sci STKE 2005;295:pe40.

Mehrabian M. , Allayee H. , Stockton J. , Lum PY , Drake TA , Castellani LW , et al: Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet 2005;37:1224-1233.

Cervino AC , Li G. , Edwards S. , Zhu J. , Laurie C. , Tokiwa G. , et al: Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics 2005; 86:505-517.

Stockwell BR : Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet 2000;1:116-125.

Lokey RS : Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia . Curr Opin Chem Biol 2003 ;7:91-96.

Liu J. , Farmer JD , Lane WS , Friedman J. , Weissman I. , Schreiber SL : Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-815.

10.

Brown EJ , Albers MW , Shin TB , Ichikawa K. , Keith CT , Lane WS , et al: A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994;369:756-758.

11.

Sin N. , Meng L. , Wang MQ , Wen JJ , Bornmann WG , Crews CM : The antiangiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A 1997;94:6099-6103.

12.

Newgard CB , Lu D. , Jensen MV , Schissler J. , Boucher A. , Burgess S. , et al: Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach. Diabetes 2002;Suppl 3:S389-S393.

13.

Malo N. , Hanley JA , Cerquozzi S. , Pelletier J. , Nadon R. : Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006;24: 167-175.

14.

Lacy PE , Kostianovsky M. : Method for the isolation of intact islets of Langerhans from the rat pancreas . Diabetes 1967;16:35-39.

15.

Herrington J. , Zhou YP , Bugianesi RM , Dulski PM , Feng Y. , Warren VA , et al: Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretion. Diabetes 2006; 55:1034-1042.

16.

Zhou YP , Berggren PO , Grill V. : A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes 1996;45:580-586.

17.

Hohmeier HE , Mulder H. , Chen G. , Henkel-Rieger R. , Prentki M. , Newgard CB : Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000;49:424-430.

18.

Boucher A. , Lu D. , Burgess SC , Telemaque-Potts S. , Jensen MV , Mulder H. , et al: Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem 2004;279:27263-27271.

19.

Schisler JC , Jensen PB , Taylor DG , Becker TC , Knop FK , Takekawa S. , et al: The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc Natl Acad Sci U S A 2005;102:7297-7302.

20.

Jensen MV , Joseph JW , Ilkayeva O. , Burgess S. , Lu D. , Ronnebaum SM , et al: Compensatory responses to pyruvate carboxylase suppression in islet beta-cells: preservation of glucose-stimulated insulin secretion. J Biol Chem 2006;281:22342-22351.

21.

Smith PA , Rorsmann P. , Ashcroft FM : Modulation of dihydropyridine-sensitive Ca2+ channels by glucose metabolism in mouse pancreatic beta-cells. Nature 1989 ;342:550-553.

22.

Ashcroft FM : Ca2+ channels and excitation-contraction coupling . Curr Opin Cell Biol 1991;3:671-675.

23.

Ashcroft FM , Proks P. , Smith PA , Ammala C. , Bokvist K. , Rorsman P. : Stimulus-secretion coupling in pancreatic beta cells. J Cell Biochem 1994;55(Suppl):54-65.

24.

Sharp GW : The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia 1979;16:287-296.

25.

Drucker DJ , Philippe J. , Mojsov S. , Chick WL , Habener JF : Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 1987;84:3434-3438.

26.

Leibowitz MD , Biswas C. , Brady EJ , Conti M. , Cullinan CA , Hayes NS , et al: A novel glucose-dependent insulin secretagogue is a phophodiesterase inhibitor. Diabetes 1995;44:67-74.

27.

Pyne NJ , Furman BL : Cyclic nucleotide phosphodiesterases in pancreatic islets. Diabetologia 2003;46:1179-1189.

28.

Johansson SM , Salehi A. , Sandstrom ME , Westerblad H. , Lundquist I. , Carlsson PO , et al: A(1) receptor deficiency causes increased insulin and glucagon secretion in mice . Biochem Pharmacol 2007;74:1628-1635.

29.

Hillaire-Buys D. , Bertrand G. , Gross R. , Loubatieres-Mariani MM : Evidence for an inhibitory A1 subtype adenosine receptor on pancreatic insulin-secreting cells. Eur J Pharmacol 1987;136:109-112.

30.

Peterhoff M. , Sieg A. , Brede M. , Chao CM , Hein L. , Ullrich S. : Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice. Eur J Endocrinol 2003;149:343-350.

31.

Devedjian JC , Pujol A. , Cayla C. , George M. , Casellas A. , Paris H. , et al: Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 2000;43:899-906.

32.

Mojsov S. , Weir GC , Habener JF : Insulinotropin: glucagon-like peptide I (7—37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas . J Clin Invest 1987;79:616-619.

33.

Fehmann HC , Goke B. , Goke R. , Trautmann ME , Arnold R. : Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas . FEBS Lett 1989;252:109-112.

34.

Alberti KG , Christensen NJ , Christensen SE , Hansen AP , Iversen J. , Lundbaek K. , et al: Inhibition of insulin secretion by somatostatin. Lancet 1973;2:1299-1301.

35.

Johnson DG , Ensinck JW , Koerker D. , Palmer J. , Goodner CJ : Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ. Endocrinology 1975;96:370-374.

36.

Ericson LE , Hakanson R. , Lundquist, I. : Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA Localization to secretory granules and inhibition of insulin secretion . Diabetologia 1977;13:117-124.

37.

Arneric SP , Chow SA , Long JP , Fischer LJ : Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine. Diabetes 1984 ;33:888-893.

38.

Rubi B. , Ljubicic S. , Pournourmohammadi S. , Carobbio S. , Armanet M. , Bartley C. , et al: Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 2005;280:36824-36832.

39.

Wishart DS , Knox C. , Guo AC , Shrivastava S. , Hassanali M. , Stothard P. , et al: Drug Bank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006;34:D668-D672.

40.

Overington JP , Al-Lazikani B. , Hopkins AL : How many drug targets are there? Nat Rev Drug Discov 2006;5:993-996.